Trifluoroacetamide

Trifluoroacetamide

SCHEMBL20915034

NC(=O)C(Cl)(Cl)Cl.NC(=O)C(F)(F)F

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.39
TP53 P04637 1/20 0.39
TSHR P16473 1/20 0.39
CA2 P00918 1/20 0.32
LMNA P02545 1/20 0.31
OR51E2 Q9H255 1/20 0.31
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30995902 0.86 ALDH1A1 (0.50) ALDH1A1TP53TSHRCA2LMNA
Trifluoroacetamide SCHEMBL142 0.86
SCHEMBL116271 0.86
Trifluoroacetamide SCHEMBL27678123 0.86 LMNA (0.42) ALDH1A1TSHRCA2LMNAOR51E2
Trifluoroacetamide SCHEMBL11793075 0.82
Trifluoroacetamide SCHEMBL16269134 0.82
Trifluoroacetamide SCHEMBL6982843 0.82
Ammonia Solution, Strong SCHEMBL21381330 0.82
Trifluoroacetamide SCHEMBL15993978 0.82 LMNA (0.50) ALDH1A1CA2LMNAOR51E2TDP1
Trifluoroacetamide SCHEMBL5638451 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200222447-A9 BIO-INSPIRED POLYMERS FOR USE AS SYNTHETIC MUCINS MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2020-07-16 US disclosed
US-20190117682-A1 BIO-INSPIRED POLYMERS FOR USE AS SYNTHETIC MUCINS MASSACHUSETTS INST TECHNOLOGY (US) 2019-04-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190117682-A1 BIO-INSPIRED POLYMERS FOR USE AS SYNTHETIC MUCINS MUC1, FUT5, ALG1 ALDH1A1 2629/4885TP53 1533/4885TSHR 3485/4885
US-20200222447-A9 BIO-INSPIRED POLYMERS FOR USE AS SYNTHETIC MUCINS MUC1, FUT5, ALG1 ALDH1A1 2629/4885TP53 1533/4885TSHR 3485/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.